Three years ago, the American company 3M has decided to close its Hurlingham plant, where it manufactured products for the auto parts, plastics and pharmaceutical sectors. But he continued to work in the country through distributors, with imported products.
Now, the company that owns the Scotch tape and the publish it and who stood out during the pandemic for their N95 masksalso decided stop selling its products in the country sanitary areaas published by the specialized site Pharmabiz.
It comes from special adhesive tapes (with brands such as Micropore or Transpore) to the inputs used in the processes of instrument sterilization surgical and infection control with Steri-Vac and Comply brands or Littmann stethoscopes.
When consultedby 3M indicated that the company “it will continue to operate in the countryreaffirming our commitment to Argentina as we have done for more than 70 years.
“We will continue to supply sanitary products to our customers in Argentina”, they added, although they did not specify whether the supply of the items will be through distributors who deal directly with the import.
The dollar shortage that Argentina has suffered in recent years has deepened both the importing securities such as the transfer of dividends outwards.
This causes many companies to get tired of dealing with the complications that the import business entails or, directly, that the additional costs that generate the new conditions leave their mark off the market.
Added to this, according to some of 3M’s competitors, is that their products they are losing ground against more specialized local rivals, since the North American company from its origin covers a wide range of products from different sectors.
“3M used to be the clear leader in some areas, but they are now losing offers in various countries. They are not pulling out of business in Argentina because you can’t do business in the country, but rather because they have lost competitiveness. They are leaving several countries in the Southern Cone,” said a businessman who supplies the same sector with 3M.
In addition, 3M is reorganizing its divisions around the world. It has already decided to spin-off its Health Care business towards the end of the year.
Thus, the “new 3M” would be left without Health, with sales of approximately $27,000 million, and another independent company focusing on wound care, oral care, healthcare technology and biopharma products, with sales of approximately US$8.5 billion.
Source: Clarin
